pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics Europe clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 25
- Drugs
- 509
- Patents
- 90
United Therapeutics Europe projects
25 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.
United Therapeutics Europe has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Erenumab
United Therapeutics Europe Ltd
Fibromyalgia
1 trial -
ITDCVC98
United Therapeutics Europe Ltd
Malaria
1 trial -
asparaginase
United Therapeutics Europe Ltd
Lymphoma
1 trial -
Autologous Fat Transfer
United Therapeutics Europe Ltd
Wound
1 trial -
Calcium Gluconate
United Therapeutics Europe Ltd
Trauma
1 trial -
Cold Stored Platelets (CSP)
United Therapeutics Europe Ltd
Trauma
1 trial -
DNA vaccine prime
United Therapeutics Europe Ltd
Malaria
1 trial -
Dinutuximab
United Therapeutics Europe Ltd
Ganglioneuroblastoma
1 trial -
Inhaled Treprostinil
United Therapeutics Europe Ltd
Sarcoidosis
1 trial -
MultiStem
United Therapeutics Europe Ltd
Trauma
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Cardiomyopathy
1 trial -
rituximab
United Therapeutics Europe Ltd
Lymphoma
1 trial -
Biospecimen Collection
United Therapeutics Europe Ltd
Glioma
1 trial -
D/ChAd63-CA
United Therapeutics Europe Ltd
Malaria
1 trial -
FMP012 with AS01B adjuvant system
United Therapeutics Europe Ltd
Malaria
1 trial -
FMP1/AS02A
United Therapeutics Europe Ltd
Malaria
1 trial -
Group 1: 10 ug FMP012 with 2 ug GLA-SE
United Therapeutics Europe Ltd
Malaria
1 trial -
Plasmodium falciparum Malaria Protein 010 (FMP010)
United Therapeutics Europe Ltd
Malaria
1 trial -
treatment A
United Therapeutics Europe Ltd
Dyslipidemia
1 trial -
AL (Coartem)
United Therapeutics Europe Ltd
Malaria
1 trial -
Amodiaquine plus Artesunate co-administration
United Therapeutics Europe Ltd
Malaria
1 trial -
Coartem™ (Artemether-lumefantrine combination)
United Therapeutics Europe Ltd
Malaria
1 trial -
Ferric carboxymaltose
United Therapeutics Europe Ltd
Anemia
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Obesity
1 trial -
iron and zinc combined
United Therapeutics Europe Ltd
Anemia
1 trial
Frequently asked questions
How many clinical projects does United Therapeutics Europe have?
25 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.